by Eve Ripley | May 17, 2017 | Company News, Media Coverage
[vc_row][vc_column][vc_column_text] Dr. Stuart Titus appeared on podcast Yew Media yesterday to discuss cannabinoid research and share the many successes that Medical Marijuana, Inc. has achieved in recent months. Radio personality Chris Cantore recently invited...
by Eve Ripley | Jan 17, 2017 | HempMeds, Kannaway, Press Releases
SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company....
by Eve Ripley | Jan 9, 2017 | Axim Biotechnologies, Press Releases
AXIM Biotechnologies Announces Positive Pharmacokinetic (PK) Data Results on Proprietary Delivery Method for Cannabinoids in Chewing Gum SAN DIEGO, CA — (Marketwired) — 01/09/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded...
by Eve Ripley | Jan 6, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...
by Eve Ripley | Jan 4, 2017 | Axim Biotechnologies, Press Releases
NEW YORK – Jan. 04, 2017 – AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating...
